# A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH

> **NCT03062280** · PHASE3 · COMPLETED · sponsor: **Neurocrine UK Limited** · enrollment: 91 (actual)

## Conditions studied

- Congenital Adrenal Hyperplasia

## Interventions

- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT03062280
- **Lead sponsor:** Neurocrine UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-18
- **Primary completion:** 2022-07-13
- **Final completion:** 2022-07-13
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062280, "A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03062280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*